Giovanna Motta

Istituto Europeo di Oncologia

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Alessandro Pileri

Associated Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

ITALY

View details

Jean‐Marie Michot

FRANCE

View details

helene Moins-Teisserenc

Professor of Immunology

Université Paris Cité

FRANCE

View details

ANNALISA CHIAPPELLA

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanna Motta

Research Interests

Explore related searches

Contact this professor

Articles (10)

A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL

Clonal T-cell proliferations occasionally occur in Kikuchi–Fujimoto disease

Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma

The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma

Histiocytic and dendritic cell neoplasms,Histiozytische und dendritische Zelltumoren

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma

Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial

Collaborators (4)

Alessandro Pileri

Jean‐Marie Michot

helene Moins-Teisserenc

ANNALISA CHIAPPELLA

Make your next move.